Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Bruker (BRKR) over the last 13 years, with Q4 2024 value amounting to $271477.0.

  • Bruker's Gains from Sales and Divestitures rose 190.77% to $271477.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $271477.0, marking a year-over-year increase of 190.77%. This contributed to the annual value of $271477.0 for FY2024, which is 190.77% up from last year.
  • According to the latest figures from Q4 2024, Bruker's Gains from Sales and Divestitures is $271477.0, which was up 190.77% from $266395.0 recorded in Q4 2023.
  • In the past 5 years, Bruker's Gains from Sales and Divestitures ranged from a high of $336728.0 in Q4 2020 and a low of $41738.0 during Q1 2020
  • Over the past 4 years, Bruker's median Gains from Sales and Divestitures value was $273279.5 (recorded in 2022), while the average stood at $225210.5.
  • As far as peak fluctuations go, Bruker's Gains from Sales and Divestitures soared by 3270.82% in 2020, and later tumbled by 522.99% in 2023.
  • Over the past 4 years, Bruker's Gains from Sales and Divestitures (Quarter) stood at $336728.0 in 2020, then dropped by 16.52% to $281096.0 in 2022, then dropped by 5.23% to $266395.0 in 2023, then grew by 1.91% to $271477.0 in 2024.
  • Its Gains from Sales and Divestitures was $271477.0 in Q4 2024, compared to $266395.0 in Q4 2023 and $281096.0 in Q4 2022.